The multiple sclerosis community has been waiting with bated breath for the approval of the drug Ocrevus (ocrelizumab), which will be used to treat patients who have relapsing ... Read more
Ocrevus was approved by the FDA at the end of March but the buzz hasn’t died down.Though there is some trepidation, the MS community is incredibly excited ... Read more
In this video from the Healthcare Channel, Dr. Jerry S. Wolinsky talks about the results of an Ocrelizumab (Ocrevus) clinical trial for primary-progressive multiple sclerosis (PPMS) patients. MORE: What the world ... Read more
Ocrevus (ocrelizumab) is a newly FDA-approved therapy for multiple sclerosis. It can be used to treat two forms of the disease: relapsing-remitting MS (RRMS) and primary progressive MS ... Read more
It’s been less than a month since Ocrevus was approved by the FDA, and the buzz hasn’t died down. Though there is some trepidation, the MS ... Read more
Pamela Arterbridge is one of 70 people at Ohio State University’s Multiple Sclerosis Center taking part in the open-label part of a clinical trial for ocrelizumab, now best ... Read more
History has been made because of a major breakthrough for multiple sclerosis sufferers everywhere. Ocrevus (ocrelizumab), by Genentech, has been finally approved by the U.S. Food and ... Read more
There is now less than a month until the U.S. Food and Drug Administration (FDA) is expected to approve Ocrevus, generic name ocrelizumab, for use as ... Read more
In this video from the Vall d’Hebron Barcelona Hospital Campus, Dr. Xavier Montalbán talks about the Phase 3 international study of a new drug developed by ... Read more
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more
